Harmony Biosciences (NASDAQ:HRMY) focuses on developing and delivering innovative treatments for neurological disorders, particularly those that affect sleep and wakefulness. With a commitment to addressing unmet medical needs, Harmony's efforts are centered on bringing forward therapies that can significantly improve patients' quality of life. A key project for the company has been the successful development and commercialization of a treatment for narcolepsy, demonstrating their dedication to enhancing healthcare outcomes for individuals dealing with challenging conditions. Harmony Biosciences aims to expand its portfolio through strategic collaborations, ongoing research, and the exploration of novel therapeutics to further its objective of transforming lives through science.